SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-069000
Filing Date
2014-09-29
Accepted
2014-09-29 17:26:52
Documents
3
Period of Report
2014-09-29
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-21611_18k.htm 8-K 25298
2 EX-3.1 a14-21611_1ex3d1.htm EX-3.1 54465
3 EX-99.1 a14-21611_1ex99d1.htm EX-99.1 6376
  Complete submission text file 0001104659-14-069000.txt   87525
Mailing Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034
Business Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034 215-461-2000
Vitae Pharmaceuticals, Inc (Filer) CIK: 0001157602 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36617 | Film No.: 141127778
SIC: 2834 Pharmaceutical Preparations